These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 14630235

  • 1. Quinoxalin-2-ones. Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety.
    Carta A, Loriga M, Zanetti S, Sechi LA.
    Farmaco; 2003 Dec; 58(12):1251-5. PubMed ID: 14630235
    [Abstract] [Full Text] [Related]

  • 2. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
    Carta A, Paglietti G, Rahbar Nikookar ME, Sanna P, Sechi L, Zanetti S.
    Eur J Med Chem; 2002 May; 37(5):355-66. PubMed ID: 12008050
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation for biological activity of 3-alkyl and 3-halogenoalkyl-quinoxalin-2-ones variously substituted. Part 4.
    Carta A, Sanna P, Loriga M, Setzu MG, La CP, Loddo R.
    Farmaco; 2002 Jan; 57(1):19-25. PubMed ID: 11902641
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antimicrobial activity of 2,3-bis(bromomethyl)quinoxaline derivatives.
    Ishikawa H, Sugiyama T, Kurita K, Yokoyama A.
    Bioorg Chem; 2012 Jan; 41-42():1-5. PubMed ID: 22245018
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of 2,3-bis(halomethyl)quinoxaline derivatives and evaluation of their antibacterial and antifungal activities.
    Ishikawa H, Sugiyama T, Yokoyama A.
    Chem Pharm Bull (Tokyo); 2013 Jan; 61(4):438-44. PubMed ID: 23546003
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
    Carta A, Loriga M, Paglietti G, Mattana A, Fiori PL, Mollicotti P, Sechi L, Zanetti S.
    Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of some novel triazol-3-ones as antimicrobial agents.
    Pardeshi S, Bobade VD.
    Bioorg Med Chem Lett; 2011 Nov 01; 21(21):6559-62. PubMed ID: 21920741
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
    Tomar V, Bhattacharjee G, Kamaluddin, Kumar A.
    Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5321-4. PubMed ID: 17719779
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA, Wahab AE.
    Arch Pharm (Weinheim); 2006 Aug 01; 339(8):437-47. PubMed ID: 16881038
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial and genotoxic activities of N-substituted 2,2'-dicarboxamidodiphenyldisulfides.
    Zani F.
    Farmaco; 1992 Feb 01; 47(2):219-28. PubMed ID: 1510794
    [Abstract] [Full Text] [Related]

  • 11. Novel ethyl 1,5-disubstituted-1H-pyrazole-3-carboxylates as a new class of antimicrobial agents.
    Radwan AA, Ghorab MM, Alsaid MS, Alanazi FK.
    Acta Pharm; 2014 Sep 01; 64(3):335-44. PubMed ID: 25296679
    [Abstract] [Full Text] [Related]

  • 12. Green route for the heterocyclization of 2-mercaptobenzimidazole into beta-lactum segment derivatives containing -CONH- bridge with benzimidazole: Screening in vitro antimicrobial activity with various microorganisms.
    Desai KG, Desai KR.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8271-9. PubMed ID: 17035035
    [Abstract] [Full Text] [Related]

  • 13. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
    Carta A, Sanna P, Gherardini L, Usai D, Zanetti S.
    Farmaco; 2001 Dec 15; 56(12):933-8. PubMed ID: 11829113
    [Abstract] [Full Text] [Related]

  • 14. Chemoenzymatic synthesis and antimicrobial activity evaluation of monoglucosyl diglycerides.
    Cateni F, Bonivento P, Procida G, Zacchigna M, Gabrielli Favretto L, Scialino G, Banfi E.
    Bioorg Med Chem; 2007 Jan 15; 15(2):815-26. PubMed ID: 17088068
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and biological studies of substituted quinozoline-4-(3H)-ones containing diazepine moiety.
    Narayana Rao DV, Raghavendra Guru Prasad A, Spoorthy YN, Pariplavi M, Ravindranath LK.
    Ann Pharm Fr; 2014 Jan 15; 72(1):51-8. PubMed ID: 24438669
    [Abstract] [Full Text] [Related]

  • 16. Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3.
    Sanna P, Carta A, Loriga M, Zanetti S, Sechi L.
    Farmaco; 1999 Mar 31; 54(3):169-77. PubMed ID: 10371030
    [Abstract] [Full Text] [Related]

  • 17. Discovery and evaluation of efficient selenazoles with high antifungal activity against Candida spp.
    Laczkowski KZ, Misiura K, Biernasiuk A, Malm A.
    Med Chem; 2015 Mar 31; 11(2):118-27. PubMed ID: 25176418
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and study of antibacterial and antifungal activities of novel 1-[2-(benzoxazol-2-yl)ethoxy]- 2,6-diarylpiperidin-4-ones.
    Ramalingan C, Balasubramanian S, Kabilan S, Vasudevan M.
    Eur J Med Chem; 2004 Jun 31; 39(6):527-33. PubMed ID: 15183911
    [Abstract] [Full Text] [Related]

  • 19. [New methyl-quinoxaline derivatives with antimicrobial activity].
    Ungureanu M, Poiată A, Tuchiluş C.
    Rev Med Chir Soc Med Nat Iasi; 2004 Jun 31; 108(1):181-4. PubMed ID: 15688781
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
    Yildiz-Oren I, Tekiner-Gulbas B, Yalcin I, Temiz-Arpaci O, Aki-Sener E, Altanlar N.
    Arch Pharm (Weinheim); 2004 Jul 31; 337(7):402-10. PubMed ID: 15237391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.